Both in mouse mammary tumors and in human breast cancers, we observed elevation of Vim, Cdh2 (N-cadherin), Snai1 and Twist1 and downregulation of Cdh1 (E-cadherin) and Ocln (Figs 4, 5; supplementary material Fig. S3). This evidence concerns the gene OCLN and breast cancer.